Pharmaceutical Compositions And Method For Treating, Reducing, Ameliorating, Alleviating, Or Preventing Dry Eye


A composition for treating, reducing, ameliorating, alleviating, or preventing a dry eye condition or an ophthalmologic disorder that has an etiology in inflammation comprises an inhibitor of activity of poly(ADP-ribose) polymerase ("PARP"). The composition can also include a modulator of pro-inflammatory gene expression.

Download PDF
Document Preview
Document History
  • Publication: Dec 18, 2008
  • Application: May 20, 2008
    WO US 2008/0064231 W
  • Priority: Jun 8, 2007
    US US 94284207 P

Download Citation

Sign in to the Lens